Pay in 4 interest-free payments of $5.46 Learn more
Ships within 48 hours · Estimated delivery Aug 31 - Sep 5
doi: 10.3389/fnins.2021.630016 Received 16 November 2020 Accepted 20 January 2021 Published 05 February 2021 Volume 15 - 2021 Edited by Matthew William Pitts, University of Hawaii at Mnoa, United States Reviewed by Frederick P
FEP maintains a managed formularycheck the 2026 FEP formulary at fepblue.org for current Zepbound status
Many patients use semaglutide or tirzepatide for 12 to 24 months to reach a goal weight, then transition to a lower maintenance dose or a structured taper while keeping lifestyle gains in place
It is typically more expensive than other formulations
US$ 24.84
US$ 23.59
US$ 23.34
US$ 28.17
